KBSA301

· Aridis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KBSA301, covering 2020-04-08 to 2020-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus) [Phase 1, Phase 2]